SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-017212
Filing Date
2016-01-05
Accepted
2016-01-05 18:32:11
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3373
  Complete submission text file 0001179110-16-017212.txt   4600
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ALTERNATIVE MANAGEMENT LP 1330 SIXTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address
Morenstein Scott D (Reporting) CIK: 0001576113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 161324542